This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Edwards, JenaValve oppose FTC request to extend restraining order

( January 8, 2026, 20:54 GMT | Official Statement) -- MLex Summary: Edwards Lifesciences and JenaValve Technology filed their opposition to a request by the US Federal Trade Commission to extend the temporary restraining order keeping the parties from consummating their merger, saying it should be denied by the court. The defendants argued that the government's proposal ignores the deal termination date of January 23, 2026, a judicial review can continue after the companies close, and "there is no legal authority for the TRO 'extension' that the FTC seeks." See document attached....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login